BrainsWay: Q1 Earnings Insights

BrainsWay (NASDAQ:BWAY) reported its Q1 earnings results on Wednesday, May 17, 2023 at 07:30 AM. Here’s what investors…

BrainsWay (NASDAQ:BWAY) reported its Q1 earnings results on Wednesday, May 17, 2023 at 07:30 AM.

Here’s what investors need to know about the announcement.

Earnings

BrainsWay missed estimated earnings by 40.0%, reporting an EPS of $-0.14 versus an estimate of $-0.1.

Revenue was down $1.34 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.11 which was followed by a 1.57% increase in the share price the next day.

Here’s a look at BrainsWay’s past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.13 -0.06 -0.05
EPS Actual -0.24 -0.30 -0.14 -0.12
Revenue Estimate 6.20M 8.44M 8.47M 8.47M
Revenue Actual 6.03M 5.17M 8.01M 7.97M

To track all earnings releases for BrainsWay visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Sangamo Therapeutics’s Earnings Outlook

Sangamo Therapeutics (NASDAQ:SGMO) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Sangamo Therapeutics will report an earnings per share (EPS) of $-0.35.

SGMO